New gene therapy offers hope for babies born without an immune system
NCT ID NCT03538899
Summary
This study is testing a new gene therapy for children with Artemis-SCID, a rare and life-threatening disorder where babies are born without a working immune system. Doctors take a child's own blood stem cells, use a modified virus to insert a healthy copy of the missing gene, and then return the corrected cells to the patient. The goal is to safely rebuild a lasting immune system without the need for a donor transplant, potentially offering a better treatment option for these children.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE COMBINED IMMUNODEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco (UCSF) Children's Hospital
RECRUITINGSan Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.